Name | Glycyl-L-Glutamine |
Synonyms | Gly-Gln-OH Gly-L-Gln-OH glycylglutamine glycyl-L-glutamine Glycyl-L-Glutamine N2-Glycyl-L-glutamine L-GlutaMine, N2-glycyl- GlutaMine,N2-glycyl-, L- (8CI) (S)-5-AMino-2-(2-aMinoacetaMido)-5-oxopentanoic acid β-Endorphin (30-31) (bovine, camel, mouse, ovine)Gly-Gln |
CAS | 13115-71-4 |
EINECS | 700-144-0 |
InChI | InChI=1/C7H13N3O4/c8-3-6(12)10-4(7(13)14)1-2-5(9)11/h4H,1-3,8H2,(H2,9,11)(H,10,12)(H,13,14) |
Molecular Formula | C7H13N3O4 |
Molar Mass | 203.2 |
Density | 1.359±0.06 g/cm3(Predicted) |
Melting Point | 194°C |
Boling Point | 643.1±55.0 °C(Predicted) |
Specific Rotation(α) | -6.5 º (c=10, 2N HCl) |
Flash Point | 342.7°C |
Water Solubility | 154 g/L (20 ºC) |
Solubility | Aqueous Acid (Slightly), Water (Slightly) |
Vapor Presure | 0Pa at 25℃ |
Appearance | White to white-like powder |
Color | White to Off-White |
pKa | 3.11±0.10(Predicted) |
Storage Condition | Keep in dark place,Inert atmosphere,Store in freezer, under -20°C |
Stability | Hygroscopic |
Sensitive | Easily absorbing moisture |
Refractive Index | -7 ° (C=3, 1mol/L HC |
MDL | MFCD00077124 |
In vitro study | Glycyl-glutamine (Glycyl-L-glutamine) is an activate and stable glutamine-containing neuropeptide. Glycyl-glutamine (Glycyl-L-glutamine) has an advantage over free glutamine(Gln) as growth factors for cell culture during both autoclaving and storage. |
In vivo study | Glycyl-glutamine (Glycyl-L-glutamine) (0.3, 0.6, 1.0 and 10.0 nM) can dose-dependently inhibit beta-End-(1-31)-induced hypotension in pentobarbital-anesthetized rats. |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S23 - Do not breathe vapour. S24/25 - Avoid contact with skin and eyes. S37/39 - Wear suitable gloves and eye/face protection S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
WGK Germany | - |
HS Code | 29241990 |
Reference Show more | 1. [IF=5.268] Bianjing Sun et al."Macroporous bacterial cellulose grafted by oligopeptides induces biomimetic mineralization via interfacial wettability."Colloid Surface B. 2019 Nov;183:110457 |
This product is glycyl-L-glutamine monohydrate. The content of C7H13N304 shall not be less than 99.0% calculated as anhydrous.
take this product, precision weighing, add water to dissolve and quantitatively dilute to make a solution containing about 40mg per lml, according to the law (General 0621), the specific rotation of a 1.2 ° to a 2.4 °.
take this product L. 0g, add water 20ml dissolved, according to the law (General 0631),pH value should be 4.5-6.0.
take this product l. After being dissolved and diluted to 20ml with water, measure the transmittance at the wavelength of 430nm by UV-Vis spectrophotometry (General rule 0401), and the transmittance shall not be less than 98.0%.
take an appropriate amount of this product, add water to dissolve and dilute to make 0.lg of the solution, the solution should be clear, if it is turbid, compared with No. 1 turbidity standard solution (General 0902 first method), not more concentrated.
take 0.30g of this product and check it according to law (General rule 0801). Compared with the control solution made of 6.0ml of standard sodium chloride solution, it should not be more concentrated (0.02%).
take l.Og of this product and check it according to law (General rule 0802). Compared with the control solution made of 0.02% of standard potassium sulfate solution, it should not be more concentrated ().
take 0.10g of this product, vacuum distillation below 60°C, check according to law (General rule 0808), and compare with the control solution made of 0.10% of standard gasification ammonium solution, not deeper ().
take an appropriate amount of this product, add water to dissolve and dilute to prepare a solution of appropriate concentration, as a test solution; Take an appropriate amount of glycine, glutamine, glutamic acid and glycyl-glutamine, water is added to dissolve and dilute to make a solution of suitable concentration as a system-suitable solution. The separation and determination of glycine peak, glutamine peak, glutamic acid peak and glycyl-glutamine peak should meet the requirements by appropriate amino acid analyzer or high performance liquid chromatography. According to the external standard method to calculate the peak area, containing glycine not more than 1.0%, the total amount of glutamine and glutamic acid not more than 0.5%.
take this product 50mg, precision weighing, top empty bottle, precision add water lml to dissolve, sealed, as a test solution; Respectively, precision weighing ethanol, acetic acid, the appropriate amount of toluene was diluted with dimethyl sulfoxide to prepare the reference stock solution. The appropriate amount of each reference stock solution was accurately measured and diluted with water to prepare 25ug of ethanol per lml, A mixed solution of 250ug of ethyl acetate and 44.5ug of toluene was precisely weighed 1 ml, placed in a headspace bottle, sealed, and used as a reference solution. According to the test for determination of residual solvents (General rule 0861, second method), a capillary column with 5% phenyldimethicone (or similar polarity) as the stationary liquid; The initial temperature is 40°C, and the retention time is 6 minutes, the temperature was increased to 160°C at a rate of 10°C per minute for 3 minutes; The inlet temperature was 200°C; The detector temperature was 250°C; The equilibrium temperature of the headspace bottle was 80°C, the equilibration time was 40 minutes. The separation degree between the main peaks shall meet the requirements when the reference solution is injected in the headspace. The reference solution and the test solution were injected into the headspace, and the chromatogram was recorded. According to the external standard method, the residual amount of ethanol shall not exceed 0.05%, and the residual amount of ethyl acetate and toluene shall comply with the regulations.
take this product, according to the moisture determination method (General 0832 first method 1), the moisture content should be 7.0% ~ 9.0%.
take this product, check according to law (General 0841), residue shall not exceed 0.1%.
take l.Og of this product and check it according to law (General rule 0807). Compared with the control solution made of 0.001% of standard iron solution, it shall not be deeper ().
take 2.0g of this product, inspection according to law (General rule 0821 third law), containing heavy metals shall not exceed 5 parts per million.
take 2.0g of this product, add 23ml to dissolve, add 5ml of hydrochloric acid, check according to law (General rule 0822 first law), should comply with the provisions (0.0001%).
take this product, check according to law (General rule 1143), each lg glycyl glutamine containing endotoxin amount should be less than 6EU. (For injection)
take this product about 0.15g, precision weighing, add anhydrous formic acid 2ml, glacial acetic acid 40ml, according to the potential titration method (General rule 0701), with perchloric acid titration solution (0.1 mol/L) titration, and the results of the titration were corrected with a blank test. Each 1 ml of perchloric acid titration solution (0.1 mol/L) corresponds to 20.32mg of C7H13N3O4.
amino acid drugs.
sealed storage.
LogP | -6.25--5.12 at 25℃ and pH1-13 |
surface tension | 71.9mN/m at 1g/L and 20 ℃ |
preparation | using glycine and L-glutamine as the main raw materials, glycine is protected by phthalic anhydride first, the obtained intermediate product and thionyl chloride generate acyl chloride, then amidation with L-glutamine, and finally deprotection with hydrazine hydrate in methanol to obtain the product, and the crude product can reach the pharmaceutical level after one-time refining. |
Use | Glycyl-L-glutamine is used as a thermostable substitute for glutamine in mammalian cell culture medium. As an amino acid nutritional drug, it can be used to improve the cellular immune function of patients. Effectively reduce the risk of infection in critically ill patients, especially for the treatment and recovery of critically ill patients such as severe infections and malignant tumors. APIs can be used as drugs alone, can also be compounded with other amino acids, and can also develop health products. |
biological activity | Glycyl-glutamine (Glycyl-L-glutamine), an enzyme cleavage product of β-endorhin, is an endogenous antagonist of β-endorphin (1-31). Glycyl-glutamine (Glycyl-L-glutamine) is an active neuropeptide that is more stable than glutamine (Gln). |